Cargando…
Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
Arsenic trioxide (As(2)O(3)) is a novel anticancer agent, which has been found to induce remission in acute promyelocytic leukaemic patients following daily intravenous administration. The therapeutic value of As(2)O(3) in other cancers is still largely unknown. Cytotoxic tests in a panel of cancer...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1999
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374294/ https://www.ncbi.nlm.nih.gov/pubmed/10555748 http://dx.doi.org/10.1038/sj.bjc.6690766 |